Quoin Pharmaceuticals, Ltd. American Depositary Shares
$7.06
$0.05 (+0.71%)
$6.70Day Range$7.15
Key Statistics
Market Cap
$14.18M
Shares Outstanding
2.0M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Oct 28, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$6.85
Day High
$7.15
Day Low
$6.70
Volume
15.6K
VWAP
$6.96
Prev Close
$7.01
Transactions
--
Acc. Volume
--
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
PHARMACEUTICAL PREPARATIONSSIC 28346 employees23 HATA'AS STREET, KFAR SABA, 4442597299741444IPO Oct 28, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001671502
- Composite FIGI
- BBG00D9PB2L6
- Share Class FIGI
- BBG00D9PB389
- Ticker Root
- QNRX
- SIC Code
- 2834
About Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) Stock
Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) closed the 2026-09-18 session at $7.06, up 0.71% versus the previous close (+0.05). The stock opened at $6.85 and traded between $6.70 and $7.15 during that session. Session trading volume was 16K shares. The volume-weighted average price (VWAP) is $6.96.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Quoin Pharmaceuticals, Ltd. American Depositary Shares has a market capitalization of $14.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. QNRX is listed on the XNAS exchange. The company employs approximately 6 people. The recorded listing date is 2021-10-28.
On this page you can find market QNRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.